ファルシャド グイラクホオゲルハルド フフルマンンキャサリン コヘンベラ バウムガルトル‐ストラスセルアンドレアス アスペックマヌエラ カイネルベルンハルド ブリムベティナ キエフマンンエリザベス ワトソンマリオ アイストレイトフネル...
Immobilized Varicella zoster virus (strain Oka vaccine) Envelope Glycoprotein E (gE), His Tag (Cat. No. GLE-V52H3) at 1 μg/mL (100 μL/well) can bind Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (4G2) with a linear range of 0.08-1 ng/mL (QC tested). HSV-gB Immobilized HS...
1 This report from the Institute of Medicine was highly influential in identifying a need for CMV vaccine but, at the time, there were no candidate vaccines which had proceeded to Phase II clinical trials and many sceptics were unconvinced that it would ever be possible to make a CMV vaccine...
6.SCARPINI S, MORIGI F, BETTI L, et al. Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice[J]. Vaccines, 2021,9(6): 551. 7.宋雅琴,人巨细胞病毒疫苗的研究策略及方向微生物学免疫学进展202310.13309/j.cnki.pmi.2023.01.009 https...
原始出处:Scott G. Hansen et al. A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge. Science Translational Medicine, 2019, doi:10.1126/scitranslmed.aaw2607. 原标题:Science子刊:一种新型CMV减毒活疫苗有望长期有效地抵抗HIV攻击...
[7] Plotkin SA, Boppana SB. Vaccination against the human cytomegalovirus.Vaccine 2018. Available athttps://www.ncbi.nlm.nih.gov/pubmed/29622379/.
让HCMV发生突变,应当能够产生一种强效但是受到限制的HCMV病毒载体,从而可能在人体中广泛使用。 参考资料: Scott G. Hansen et al. A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge. Science Translational Medicine, 2019, doi:10.1126/scitranslmed.aaw2607....
[2] Clin Vaccine Immunol. 2009 Nov;16(11):1700-3. [3] Lancet Infect Dis 2004; 4725-38 . [4] Am J Kidney Dis. 2011 Jul; 58(1):118-26.doi:10.1053 / j.ajkd.2011.04.010. [5]肾脏病与透析肾移植杂志,2004(01):51-52.
当前的这项研究有助于开发出用于人类的常规性埃博拉病毒疫苗,也有助于为类人猿提供开发出抵抗埃博拉病毒的自我传播疫苗(self-disseminating vaccine),此外还有助于开发针对目前主要在野生动物宿主中出现的其他传染性疾病的疫苗。
A cytomega- lovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer. Journal of immunotherapy (Hagerstown, Md: 1997). 2012; 35(5):390- 9. 8. Dekhtiarenko I, Jarvis MA, Ruzsics Z...